Phase II Trial of AS902330 as Adjunct to Microfracture in Cartilage Injury

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001431-31

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to evaluate the effect of AS902330 intra-articular (i.a.) knee injections as adjunct to microfracture (MFx) surgery on the composition of the refilled cartilage in the target knee, as measured by delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) T1 relaxation time at 6 months after MFx surgery.


Critère d'inclusion

  • Knee Cartilage Injury

Liens